JPRN-UMIN000027250招募中未知
Precision medicine of methotrexate in the patients with rheumatoid arthritis - Methotrexate precision medicine
Keio University Fukuoka Tokushukai Hospital0 个研究点目标入组 50 人开始时间: 2017年5月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients including infectious disease (Hepatitis B, C, HIV, syphilis) ministration of MTX
研究者
相似试验
已完成
不适用
Personalized therapy for methotrexate in patients with rheumatoid arthritisRheumatoid arthiritisJPRN-UMIN000017104Faculty of Pharmacy, Keio Univeristy Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University300
尚未招募
不适用
Treatment with high dose Methotrexate in patients with generalized eosinophilic fasciitisShulman's syndrome or diffuse fasciitis10010761NL-OMON30014niversitair Medisch Centrum Sint Radboud6
进行中（未招募）
不适用
Treatment with high dose Methotrexate in patients with eosinophilic fasciitis - High dose Methotrexate in eosinophilic fasciitisEosinophilic fasciitis (EF) is a skin disorder involving the deep fascia, resulting in pain and swelling of extremities, cutaneous induration and joint contractures. Most patients require therapy. No controlled trials have been reported. we treated EF patients with intramuscular Methotrexate (MTX)1 mg/kg weekly. In general, the results were not satisfactory and side-effects frequent. With high dose intravenous MTX4 mg/kg every four weeks, we expect a better effect with less side effects.EUCTR2006-003123-37-NLniversity Hospital Sint Radboud
已完成
不适用
Effects of Methotrexate on oral lichen planuslichen planus.Other lichen planusIRCT2013121715655N2Tehran University Of Medical Sciences15
已完成
2 期
Study of methotrexate for the control of chronic inflammation in sickle cell disease patientsPatients with Sickle cell diseaseD57.0RBR-2s9xvnCentro Infantil Boldrini